Lexicon Pharmaceuticals Stock

Lexicon Pharmaceuticals Liabilities 2024

Lexicon Pharmaceuticals Liabilities

136.32 M USD

Ticker

LXRX

ISIN

US5288723027

WKN

A14SSK

In 2024, Lexicon Pharmaceuticals's total liabilities amounted to 136.32 M USD, a 76.58% difference from the 77.2 M USD total liabilities in the previous year.

Lexicon Pharmaceuticals Aktienanalyse

What does Lexicon Pharmaceuticals do?

Lexicon Pharmaceuticals Inc is a biopharmaceutical company based in The Woodlands, Texas, USA. It was founded in 1995 and focuses on the discovery and development of novel drugs for the treatment of diseases that have not been adequately treated. Lexicon Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Lexicon Pharmaceuticals's Liabilities

Lexicon Pharmaceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Lexicon Pharmaceuticals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Lexicon Pharmaceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Lexicon Pharmaceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Lexicon Pharmaceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Lexicon Pharmaceuticals stock

What is the level of liabilities of Lexicon Pharmaceuticals this year?

Lexicon Pharmaceuticals has a debt balance of 136.32 M USD this year.

What were the liabilities of Lexicon Pharmaceuticals compared to the previous year?

The liabilities of Lexicon Pharmaceuticals have increased by 76.58% increased compared to the previous year.

What are the consequences of high debt for investors of Lexicon Pharmaceuticals?

High liabilities can pose a risk for investors of Lexicon Pharmaceuticals, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Lexicon Pharmaceuticals?

Low liabilities mean that Lexicon Pharmaceuticals has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Lexicon Pharmaceuticals affect the company?

An increase in liabilities of Lexicon Pharmaceuticals can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Lexicon Pharmaceuticals affect the company?

A decrease in the liabilities of Lexicon Pharmaceuticals can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Lexicon Pharmaceuticals?

Some factors that can influence the liabilities of Lexicon Pharmaceuticals include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Lexicon Pharmaceuticals so important for investors?

The liabilities of Lexicon Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Lexicon Pharmaceuticals take to modify the liabilities?

To change its liabilities, Lexicon Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Lexicon Pharmaceuticals pay?

Over the past 12 months, Lexicon Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Lexicon Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Lexicon Pharmaceuticals?

The current dividend yield of Lexicon Pharmaceuticals is .

When does Lexicon Pharmaceuticals pay dividends?

Lexicon Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Lexicon Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Lexicon Pharmaceuticals located?

Lexicon Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Lexicon Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lexicon Pharmaceuticals from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did Lexicon Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of Lexicon Pharmaceuticals in the year 2023?

In the year 2023, Lexicon Pharmaceuticals distributed 0 USD as dividends.

In which currency does Lexicon Pharmaceuticals pay out the dividend?

The dividends of Lexicon Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Lexicon Pharmaceuticals

Our stock analysis for Lexicon Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lexicon Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.